STAFF
Dr. José Manuel González Navajas
Assistant Professor, Department of Pharmacology, Universidad Miguel Hernandez
Unit
Pharmacology and Immunology
Subunit
Immunology of hepatic and digestive diseases
Group
Immunology of liver and colon cancer
+ 34 965 91 39 28
RESEARCH FIELDS
- Immunobiology of hepatic and digestive diseases.
- Study of the role of the Inflammasome complex during chronic liver inflammation and cancer.
- Study of the impact of T helper 17 (Th17) cells on the development of liver cancer and the efficacy of immune checkpoint inhibition therapy.
PROFESSIONAL BACKGROUND
- Previous positions:
1. Senior Researcher, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain, 2020-present.
2. Associate Professor, Universidad Miguel Hernández (UMH), Spain, 2019-present.
3. ‘Miguel Servet’ Researcher of the Spanish National Health System, FISABIO Foundation, Alicante General Hospital, Spain, 2010-2019.
4. Assistant Project Scientist, Dept. of Medicine, University of California San Diego (UCSD), USA, 2010-2013.
- Postdoctoral positions:
1. Postdoctoral Employee, Dept. of Medicine, University of California San Diego (UCSD), USA, 2006-2010.
2. Postdoctoral Fellowship, Spanish Association for the Study of the Liver (AEEH). Dept. of Medicine, University of California San Diego, USA, 2005-2006.
3. Postdoctoral Fellowship, Dept. of Clinical Medicine, Universidad Miguel Hernández (UMH), Spain, 2004-2005. - PhD in Biology. Universidad de Alicante, Spain (2003).
- Degree in Biology. Universidad de Alicante, Spain (1999).
REPRESENTATIVE PUBLICATIONS
Martínez-Cardona, C. et al. (2018)
Internatinal Journal of Cancer, DOI: 10.1002/ijc.31827
AIM2 deficiency reduces the development of hepatocellular carcinoma in mice.
Bertin, S. et al. (2015)
Mucosal Immunology, DOI: 10.1038/mi.2014.84
Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice.
Lozano-Ruiz, B. et al. (2015)
Journal of Hepatology, DOI: 10.1016/j.jhep.2014.08.027
Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis.
González-Navajas, J. M. et al. (2012)
Nature Reviews Immunology , DOI: 10.1038/nri3133
Immunomodulatory functions of type I interferons.
González-Navajas, J. M. et al. (2010)
Journal of Experimental Medicine, DOI: 10.1084/jem.20101326
Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9–driven antiinflammatory cytokine production.
González-Navajas, J. M. et al. (2010)
Journal of Clinical Investigation, DOI: 10.1172/JCI40055
TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice.